Skip to main content
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
27.08
+1.06 (4.07%)
Apr 28, 2026, 5:29 PM CET

Hansa Biopharma AB Revenue

Hansa Biopharma AB had revenue of 34.57M SEK in the quarter ending March 31, 2026, a decrease of -47.90%. This brings the company's revenue in the last twelve months to 190.49M, up 4.84% year-over-year. In the year 2025, Hansa Biopharma AB had annual revenue of 222.27M with 29.74% growth.

Revenue (ttm)
190.49M
Revenue Growth
+4.84%
P/S Ratio
14.47
Revenue / Employee
1.56M
Employees
122
Market Cap
2.76B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025222.27M50.95M29.74%
Dec 31, 2024171.32M37.22M27.76%
Dec 31, 2023134.09M-20.43M-13.22%
Dec 31, 2022154.53M120.65M356.12%
Dec 31, 202133.88M27.78M455.56%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vicore Pharma Holding AB 3.82M
Egetis Therapeutics AB 62.40M
Flerie AB 1.80M
Saniona AB 434.40M
BioInvent International AB 226.50M
Genovis AB (publ.) 129.65M
Xspray Pharma AB 2.47M
Medivir AB 8.51M
Revenue Rankings

Hansa Biopharma AB News

More News